NDC 72162-1813-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1813
- Requested NDC
- 72162-1813-01
- Package NDCs from labels
- 72162-1813-1, 72162-1813-2, 72162-1813-4, 72162-1813-6, 72162-1813-7, 72162-1813-8, 72162-1813-9, 72162-1813-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1813-1 | Gabapentin | 100 in 1 BOTTLE | CAPSULE | 100 | 103 | |
| 72162-1813-2 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 103 | |
| 72162-1813-4 | Gabapentin | 20 in 1 BOTTLE | CAPSULE | 20 | 103 | |
| 72162-1813-6 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 103 | |
| 72162-1813-7 | Gabapentin | 180 in 1 BOTTLE | CAPSULE | 180 | 103 | |
| 72162-1813-8 | Gabapentin | 84 in 1 BOTTLE | CAPSULE | 84 | 103 | |
| 72162-1813-9 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1813 | GABAPENTIN CAPSULE [BRYANT RANCH PREPACK] | 103 | Current NDC, 7 package rows | 20241122_7b404ab9-8a7e-49d4-920f-487875d14e45.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1813-1 | EA - Each | 72162-1813 | 8856c4e8-137b-44a5-808d-f98066f19826 | 1 | 2023-10-16 |
| 72162-1813-2 | EA - Each | 72162-1813 | a183c871-091d-44cf-9543-d7001ec1c283 | 1 | 2023-10-16 |
| 72162-1813-4 | EA - Each | 72162-1813 | b07e71dd-2f20-45ee-991b-6c6439d04975 | 1 | 2023-10-16 |
| 72162-1813-6 | EA - Each | 72162-1813 | 9e445edb-c461-4927-b6b3-e05adc58973d | 1 | 2023-10-16 |
| 72162-1813-7 | EA - Each | 72162-1813 | c96e5a2f-b40c-487c-ba7d-b9d07d0426c2 | 1 | 2023-10-16 |
| 72162-1813-8 | EA - Each | 72162-1813 | 67d0ac8a-2d12-4499-a0a3-e52e90e6285b | 1 | 2023-10-16 |
| 72162-1813-9 | EA - Each | 72162-1813 | ab614c8e-b9c9-4442-bd0b-61e9a0f3be0e | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | ANDA078428 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 235a6954-318a-9e3a-e063-6394a90a0e21 | 2026-06-19 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c9f0cceb-b24e-4526-b873-fedd877d6bc6 | 2026-06-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9a829dc3-b2d8-4d19-a579-0597217cec9b | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-06-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-06-08 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 5385e27c-f2fa-32d5-e063-6294a90a0a8c | 2026-06-05 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-06-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 07f07d15-ee91-8c2a-e063-6394a90a4624 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.